BioCentury
ARTICLE | Company News

Parsabiv sales and marketing update

March 1, 2017 10:51 PM UTC

Ono launched Parsabiv etelcalcetide in Japan to treat secondary hyperparathyroidism in patients on hemodialysis. The National Health Insurance (NHI) price of a 5 mg vial of Parsabiv, the starting dose...

BCIQ Company Profiles

Ono Pharmaceutical Co. Ltd.